|
| 立方制药(003020)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2025-10-20 | 79.75 | 0.42% | 13924.32 | 5232.86 | 13710.85 | 71.57% | 股权激励限售股份 | | 2025-07-21 | 28.08 | 0.15% | 13844.57 | 5312.61 | 13710.85 | 71.57% | 股权激励限售股份 | | 2024-11-11 | 105.64 | 0.55% | 13816.49 | 5340.69 | 13710.85 | 71.57% | 股权激励限售股份 | | 2023-12-15 | 4202.55 | 26.32% | 11421.21 | 4546.30 | 7218.66 | 45.21% | 首发原股东限售股份 | | 2023-11-08 | 104.32 | 0.65% | 7221.46 | 8746.05 | 7117.14 | 44.57% | 股权激励限售股份 | | 2021-12-15 | 2545.14 | 27.47% | 3853.82 | 5410.19 | 3853.82 | 41.60% | 首发原股东限售股份 |
|